Cardizem cd and Prandin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cardizem cd (diltiazem hydrochloride) and Prandin (repaglinide). Common drug interactions include chest pain among females and cerebral haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Cardizem cd and Prandin. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Cardizem cd?

Cardizem cd has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 6,045 Cardizem cd users. Check the latest studies of Cardizem cd.

What is Prandin?

Prandin has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 4,680 Prandin users. Check the latest studies of Prandin.



On Jul, 13, 2026

21 people who take Cardizem cd and Prandin together, and have interactions are studied.

Cardizem cd and Prandin drug interactions.

What are the common drug interactions of Cardizem Cd and Prandin, by gender? *:

female:

  1. Chest pain
  2. Chronic obstructive airways disease
  3. Decreased activity
  4. Depression
  5. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  6. Dissociation
  7. Drug ineffective
  8. Dyspnoea (difficult or laboured respiration)
  9. Epistaxis (bleed from the nose)
  10. Fall

male:

  1. Cerebral haemorrhage (bleeding within the brain)
  2. Dizziness
  3. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  4. Hallucination, auditory (perceiving sounds without auditory stimulus)
  5. Headache (pain in head)
  6. Hemiparesis (weakness on one side of the body)
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  8. Joint range of motion decreased (disease of joint movement)
  9. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  10. Myalgia (muscle pain)

What are the common drug interactions of Cardizem Cd and Prandin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Drug ineffective
  2. Epistaxis (bleed from the nose)
  3. Foreign body trauma (injury by foreign particle)
  4. Gastro-oesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Hyperaesthesia
  6. Hyperglycaemia (high blood sugar)
  7. Insomnia (sleeplessness)
  8. Kidney transplant rejection
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)

50-59:

  1. Blood creatinine increased
  2. Hypoglycaemia (deficiency of glucose in the bloodstream)
  3. Sweating increased (excess sweating)
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Weight increased

60+:

  1. Blood glucose increased
  2. Cerebral haemorrhage (bleeding within the brain)
  3. Blood creatinine increased
  4. Brain injury
  5. Chest pain
  6. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  7. Dissociation
  8. Drug hypersensitivity
  9. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  10. Hallucination, auditory (perceiving sounds without auditory stimulus)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 5 people, 23.81%
  2. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 4 people, 19.05%
  3. Fluid Retention (an abnormal accumulation of fluid in the blood): 4 people, 19.05%
  4. Depression: 4 people, 19.05%
  5. Migraine (headache): 3 people, 14.29%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 14.29%
  7. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 14.29%
  8. Arrhythmias (irregular heartbeat): 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Cardizem cd and Prandin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cardizem cd and Prandin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cardizem cd:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prandin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cardizem cd and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prandin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diltiazem hydrochloride and repaglinide (the active ingredients of Cardizem cd and Prandin, respectively), and Cardizem cd and Prandin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: